MARKER THERAPEUTICS, INC. Capital Expenditures
MARKER THERAPEUTICS, INC. (MRKR) reported Capital Expenditures of $99.82 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-05-11
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-03-31 was $99.82K, a 55.26% decline year-over-year.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was $12.86K, a 91.29% decline year-over-year.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $56.74K.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $82.26K.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $374.98K, a 153.94% increase from fiscal 2018.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $147.67K.
- MARKER THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $0.00.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 143 month | Payments to Acquire Property, Plant, and Equipment 146 month | Payments to Acquire Property, Plant, and Equipment 149 month | Payments to Acquire Property, Plant, and Equipment 152 month | Payments to Acquire Property, Plant, and Equipment 155 month | Payments to Acquire Property, Plant, and Equipment 158 month | Payments to Acquire Property, Plant, and Equipment 161 month | Payments to Acquire Property, Plant, and Equipment 164 month | Payments to Acquire Property, Plant, and Equipment 167 month | Payments to Acquire Property, Plant, and Equipment 170 month | Payments to Acquire Property, Plant, and Equipment 173 month | Payments to Acquire Property, Plant, and Equipment 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $99.82K 10-Q · filed 2020-05-11 | $112.68K derived: sum of 2 quarters · filed 2020-05-11 | $169.42K derived: sum of 3 quarters · filed 2020-05-11 | $251.68K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2019-12-31 | $12.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $69.60K derived: sum of 2 quarters · filed 2020-03-12 | $151.86K derived: sum of 3 quarters · filed 2020-03-12 | $374.98K 10-K · filed 2020-03-12 | ||||||||||||
| 2019-09-30 | $56.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $139.00K derived: sum of 2 quarters · filed 2019-11-12 | $362.12K 10-Q · filed 2019-11-12 | $509.79K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2019-06-30 | $82.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $305.38K 10-Q · filed 2019-08-09 | $453.05K derived: sum of 3 quarters · filed 2020-05-11 | $453.05K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2019-03-31 | $223.13K 10-Q · filed 2020-05-11 | $370.79K derived: sum of 2 quarters · filed 2020-05-11 | $370.79K derived: sum of 3 quarters · filed 2020-05-11 | $370.79K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $147.67K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $147.67K derived: sum of 2 quarters · filed 2020-03-12 | $147.67K derived: sum of 3 quarters · filed 2020-03-12 | $147.67K 10-K · filed 2020-03-12 | ||||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||||||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | |||||||||||||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 | |||||||||||||||
| 2014-06-30 | $218.63K 10-Q · filed 2014-08-18 | |||||||||||||||
| 2013-12-31 | $218.63K 10-Q/A · filed 2014-05-21 | |||||||||||||||
| 2013-09-30 | $218.63K 10-Q · filed 2013-11-19 | |||||||||||||||
| 2013-06-30 | $218.63K 10-Q · filed 2013-08-19 | |||||||||||||||
| 2013-03-31 | $218.63K 10-Q/A · filed 2013-08-19 | |||||||||||||||
| 2012-12-31 | $218.63K 10-K · filed 2013-05-15 | |||||||||||||||
| 2012-09-30 | $218.63K 10-Q · filed 2012-11-19 | |||||||||||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $218.63K 10-Q/A · filed 2012-09-12 | ||||||||||||||
| 2012-03-31 | $218.63K 10-Q · filed 2012-05-21 | |||||||||||||||
| 2011-12-31 | $218.63K 10-K · filed 2012-04-16 | |||||||||||||||
| 2011-09-30 | $218.63K 10-Q · filed 2011-11-21 | |||||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $218.63K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |